Results 231 to 240 of about 978,977 (295)

Stabilization of Miscible Aqueous Phases via Diffusion‐Controlled Multifunctional Nanoparticle‐Ligand Complexation

Advanced Functional Materials, EarlyView.
This study presents a versatile approach to harnessing miscible aqueous domains, enabling liquid‐in‐liquid compartmentalization using a barrier formed in situ rather than bulk immiscibility. The barrier forms upon the complexation of multifunctional nanoparticles and ligands at the contact boundary of aqueous phases.
Seyyed Alireza Hashemi, Mahyar Panahi‐Sarmad, Ahmadreza Ghaffarkhah, Vahid Rad, Masoud Soroush, Thomas P. Russell, Orlando J. Rojas, Mohammad Arjmand   +7 more
wiley   +1 more source

Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer. [PDF]

Biomolecules
Christopher BN, Golick L, Basar A, Reyes L, Robinson RM, Angerstein AO, Krieg C, Hobbs GA, Guttridge DC, O'Bryan JP, Dolloff NG.   +10 more
europepmc   +1 more source

Molecular farming expression of recombinant fusion proteins applied to skincare strategies. [PDF]

PeerJ
Yu G, Zhao W, Wang Y, Xu N.
europepmc   +1 more source

YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer. [PDF]

Annu Rev Cancer Biol
Driskill JH, Dermawan JK, Antonescu CR, Pan D.   +3 more
europepmc   +1 more source

Engineering of long-acting human growth hormone-Fc fusion proteins: Effects of valency, fusion position, and linker design on pharmacokinetics and efficacy. [PDF]

PLoS One
Lee T, Lee D, Jung E, Son M, Koo K, Choi J.   +5 more
europepmc   +1 more source

The APL-associated fusion proteins.

Haematologica, 1999
S. Minucci, M. Cioce, M. Maccarana, P. G. Pelicci   +3 more
openaire   +2 more sources

Enzymatic Desialylation Enables Reliable Charge Variant Characterization of Highly Glycosylated and Sialylated Fc Fusion Proteins. [PDF]

ACS Pharmacol Transl Sci
Wen X, Liu AP, Song J, Leng C, Wang J, Russo B, Thiagarajan G, Wang H, Dow XY, Hua X, Ao X, Mittal S, Gennaro L, Gunawan R.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapeutic Fusion Proteins

The AAPS Journal, 2023
Therapeutic fusion proteins are a class of hybrid constructs that combine distinct biomolecules into a single platform with the additive effects of the components. The ability to fuse two unrelated proteins provides a means to localize mechanisms to better treat a range of diseases. Fusion proteins can be designed to impart diverse functions, including
Morgan C. Marsh, Shawn C. Owen
openaire   +2 more sources

Fusion proteins form onco-condensates

Nature Structural & Molecular Biology, 2021
A spectrum of high-risk leukemias is caused by recurrent chromosomal translocations that result in the expression of fusion proteins. In a recent article in Nature, it has been demonstrated that the oncogenic properties of one such fusion, NUP98–HOXA9, are linked to its ability to self-associate and function through aberrantly phase-separated “onco ...
Tanja Mittag, Aseem Z. Ansari
openaire   +2 more sources

Fusion proteins in biotechnology

Current Opinion in Biotechnology, 1992
Gene fusion techniques allow the production of recombinant proteins featuring the combined characteristics of the parental products. Originally, these techniques were used to probe transcriptional and translational activity, to translocate proteins across cell membranes, and to facilitate the recovery of proteins.
M, Uhlén, G, Forsberg, T, Moks, M, Hartmanis, B, Nilsson   +4 more
openaire   +2 more sources